What Nitazenes Are and Why These Benzimidazole Synthetic Opioids Have Become a Hidden Overdose Threat in Tennessee
Nitazenes are not new, exactly. They were first synthesized in the 1950s as experimental pain relievers and then shelved, never approved for medical use anywhere in the United States. Decades later they resurfaced, this time in the illicit drug supply, and they have quietly become one of the more dangerous developments in the synthetic opioid crisis. The reason they are so hard to see coming is that they rarely show up on their own. In Tennessee, nitazenes have turned up mixed into other drugs, most often fentanyl and methamphetamine, so the people taking them frequently do not know they are there.
Chemically, nitazenes belong to a family called benzimidazole opioids. Like fentanyl and heroin, they act on the brain’s mu-opioid receptors, which is what makes them capable of causing the slow, shallow breathing that leads to a fatal overdose. What sets them apart is a combination of high potency in several analogs and the fact that routine drug screens often miss them, because they are chemically distinct from fentanyl.
This guide explains what nitazenes are, what Tennessee’s own overdose data shows, how the law treats them, how overdoses are reversed, and what real treatment for opioid use disorder involving nitazenes looks like. It is informational only and is not medical or legal advice.
| Nitazenes at a glance | Detail |
|---|---|
| Drug class | Benzimidazole synthetic opioids |
| Origin | Developed in the 1950s; never approved for U.S. medical use |
| Relative potency | Varies widely by analog; several exceed fentanyl |
| Forms found | Powder, pressed pills, and liquids |
| Most common Tennessee analog | Metonitazene |
| Overdose reversal | Naloxone works, but multiple doses may be needed |
How Nitazene Potency Compares to Fentanyl and Why “Stronger” Also Means Deadlier and Harder to Reverse
Potency is where nitazenes earn their fearsome reputation, but the honest version of the story is more nuanced than a single scary multiplier. The class contains many different analogs, and they are not equally strong. According to the CDC, laboratory testing shows that some nitazenes, such as isotonitazene, protonitazene, and etonitazene, greatly exceed the potency of fentanyl, while metonitazene, the one most often found in Tennessee, is roughly similar to fentanyl. A 2025 review by clinicians at Vanderbilt University Medical Center and UPMC described the class overall as capable of being more than twenty times as potent as fentanyl and hundreds to thousands of times more potent than morphine.
The practical danger is less about any one number and more about unpredictability. When a substance is that concentrated and is mixed unevenly into powders or counterfeit pills, a tiny difference in a batch can be the difference between a typical dose and a fatal one. Potency also affects rescue: naloxone still reverses nitazene overdoses, but as both the CDC and DEA note, more than one dose is often required, and effects can outlast a single administration.
What Tennessee Overdose Surveillance Data From the CDC and State Health Department Reveals About Nitazene Deaths
Tennessee happens to have some of the clearest early data in the country, in part because the Knox County Regional Forensic Center sends samples to the DEA for the specialized testing that catches nitazenes. That means the state’s numbers, while still likely an undercount elsewhere, are unusually well documented. A CDC report authored by the Tennessee Department of Health’s Office of Informatics and Analytics identified 52 nitazene-involved overdose deaths in the state between 2019 and 2021, and the year-over-year climb was steep.
Two details from that same dataset matter enormously for anyone thinking about safety. First, every single nitazene-involved death in the state also involved other substances. Nitazenes were never found alone. Second, naloxone was administered in only about a quarter of those fatal cases, a reminder that the reversal drug only helps if it is present and used in time.
The picture has kept building since. A 2025 review from Vanderbilt reported that Tennessee’s overdose reporting system counted 92 nitazene-involved fatal overdoses among state residents from 2019 through 2023, and again, every one of them involved other drugs. Nationally, the trend runs the same direction: the CDC has documented confirmed nitazene-involved overdose deaths climbing from 27 in 2020 to 409 in 2024.
92 nitazene-involved fatal overdoses among Tennessee residents, 2019 to 2023 (state overdose reporting system).
27 to 409 confirmed nitazene-involved overdose deaths nationwide, 2020 to 2024 (CDC).
For readers weighing where to seek help, our overview of the best places in Tennessee for luxury drug and alcohol rehab maps out where private treatment is concentrated across the state.
The Federal Legal Status of Nitazenes and the DEA’s 2025 Emergency Scheduling of Benzimidazole Opioids
Nitazenes are treated as dangerous controlled substances, and the federal government has been steadily closing gaps as new analogs appear. Many nitazenes are already controlled under the Controlled Substances Act, and in 2025 the DEA moved on several more.
The DEA issued a notice of intent to temporarily place seven additional benzimidazole-opioid substances into Schedule I.
Citing an imminent hazard to public safety, the DEA published an emergency temporary Schedule I order for two nitazenes, N-pyrrolidino metonitazene and N-pyrrolidino protonitazene.
Schedule I is the most restrictive category, reserved for substances with no accepted medical use and a high potential for abuse. Once these orders take effect, manufacturing, distributing, or possessing the covered substances carries federal criminal penalties. The DEA maintains a running technical resource on the class through its Diversion Control Division nitazenes page.
Recognizing a Nitazene Overdose and Why Naloxone Still Saves Lives Even Against Ultra-Potent Synthetic Opioids
Because nitazenes are opioids, an overdose looks like an opioid overdose. Warning signs include unresponsiveness, very slow or stopped breathing, choking or gurgling sounds, blue or gray lips and fingertips, and pinpoint pupils. Because nitazenes are so often mixed with other drugs, the person overdosing usually has no idea what they took.
If you suspect an overdose.
Call 911 immediately. Give naloxone if it is available, and be prepared to give more than one dose, since a single dose may not be enough for potent synthetic opioids. Stay with the person until help arrives. Public health agencies distribute naloxone widely, and it is safe to use even if you are not certain opioids are involved.
The Tennessee data underscores why access matters: naloxone was used in only a minority of the state’s fatal nitazene cases. Reversal works, but only when the medication is on hand and used quickly. Because standard drug panels can miss nitazenes, families and clinicians sometimes do not learn a nitazene was involved until toxicology comes back later.
Understanding Nitazene Dependence, Opioid Withdrawal Symptoms, and the Medically Supervised Detox Timeline
People who use nitazenes regularly, knowingly or not, can develop the same physical dependence seen with other opioids, and stopping brings opioid withdrawal. Symptoms typically include anxiety, muscle and bone aches, sweating, runny nose, nausea, diarrhea, insomnia, and powerful cravings. Withdrawal is rarely life-threatening on its own, but it is genuinely miserable and is a leading reason people relapse, which with a supply this potent can be fatal.
The timing depends heavily on what else was in the supply, since nitazenes are almost always mixed with fentanyl or other opioids. A general opioid-withdrawal course looks like this, though individual experiences vary.
hours to a day
first few days
about a week
can linger
Because the supply is unpredictable and relapse risk is so dangerous, medically supervised detox is safer than trying to stop alone, and it opens the door to the medications that actually keep people alive over the long term.
What Evidence-Based Treatment for Nitazene and Synthetic Opioid Use Disorder Actually Involves
There is no separate playbook for nitazenes. Because the underlying condition is opioid use disorder, treatment relies on the same approaches that decades of evidence support for opioids: medication combined with behavioral care. Medications for opioid use disorder, often shortened to MOUD, are the backbone, and they are the single most effective tool for reducing overdose death.
| Medication | How it works | Typical role |
|---|---|---|
| Buprenorphine | Partial agonist that eases withdrawal and cravings | Office-based, often first-line |
| Methadone | Full agonist dispensed through certified clinics | Withdrawal and maintenance |
| Naltrexone | Antagonist that blocks opioid effects | Relapse prevention after detox |
Naloxone belongs in a separate category from the medications above: it is for reversing an overdose in the moment, not for ongoing treatment. Around the medication, good programs add counseling, therapy for co-occurring depression or trauma, and relapse-prevention planning. Because nitazenes are usually part of a polysubstance picture, treatment often has to address stimulant use and other substances at the same time, which is one more reason to choose a program with real clinical depth.
What Distinguishes a Luxury or Private Nitazene Rehab Facility in Tennessee From Standard Outpatient Care
“Luxury” is often reduced to comfortable surroundings, but for a substance this dangerous, the features that matter most are clinical. The priorities are on-site or closely coordinated medical detox, experienced management of medications for opioid use disorder, and the ability to treat the polysubstance and mental-health picture that usually comes with nitazene exposure. Private and luxury programs tend to layer on smaller caseloads, more one-on-one clinician time, private accommodations, and holistic therapies that make a longer stay easier to finish. Those comforts genuinely help people stay in treatment, but they should sit on top of medical capability, not replace it.
The levels of care below make up the standard continuum, and many people move through more than one as they stabilize.
| Level of care | What it typically involves | Often suited to |
|---|---|---|
| Medical detox | 24-hour monitoring, comfort medications | Significant physical dependence |
| Residential inpatient | Live-in care with medical oversight | Unstable home or high relapse risk |
| Partial hospitalization | Full-day structure, home at night | Step-down or moderate needs |
| Intensive outpatient | Several sessions weekly around work | Milder needs, strong support |
| Outpatient MOUD | Ongoing medication and counseling | Long-term maintenance |
Cost and setting vary across the state. If you are comparing premium options, our look at the most expensive luxury rehab facilities in Tennessee and our guide to the top cities for luxury detox, executive rehab, and premium inpatient treatment give a feel for what different levels of care cost and where they sit. Because this is opioid use disorder treatment, most plans that cover addiction care apply; our breakdown of luxury rehab in Tennessee accepted through insurance coverage explains how to check your benefits.
How to Verify the Accreditation, Licensing, and Clinical Credibility of a Luxury Synthetic Opioid Rehab Provider in Tennessee
Since “luxury” is not a regulated term, the marketing tells you little about clinical quality. A few verifiable markers do. Look for accreditation from the Joint Commission or CARF, both independent bodies that audit safety and outcomes. Confirm state licensing through the Tennessee Department of Mental Health and Substance Abuse Services. Ask plainly whether the program offers medical detox and prescribes medications for opioid use disorder, because a program that does not offer buprenorphine or methadone access is missing the most effective tool available.
It is also fair to ask how a facility handles the realities specific to nitazenes: how they manage a polysubstance picture, whether they provide naloxone and overdose education to patients and families at discharge, and how they treat co-occurring mental-health conditions. Clear answers signal real expertise. Vague reassurance, pressure to commit immediately, or reluctance to discuss medication are reasons to keep looking.
A Practical, Non-Alarmist Safety Note for Anyone Affected by Nitazenes or Synthetic Opioids in Tennessee
If you or someone you love is caught up with nitazenes or an unpredictable opioid supply, help is real and effective, and none of this requires facing it alone. The single most protective steps are carrying naloxone, never using alone, and connecting with treatment. The following public resources are free and confidential:
SAMHSA National Helpline: 1-800-662-HELP (4357), available 24/7 in English and Spanish.
Find treatment near you: the SAMHSA treatment locator at findtreatment.gov.
In an overdose emergency: call 911 right away.
If you are in crisis: call or text 988 for the Suicide and Crisis Lifeline.
About this guide. This article is compiled from primary government and peer-reviewed sources, including the CDC, the Tennessee Department of Health, the DEA, and a 2025 clinical review from Vanderbilt University Medical Center and UPMC. Statistics are attributed and dated to their source. Because the illicit drug supply and scheduling actions change quickly, verify current details before making legal or medical decisions.
This content is provided for information only. It is not medical advice, legal advice, or a diagnosis, and it does not claim medical review. Always consult a licensed clinician or attorney about your own circumstances.
References and Citations
- Roberts A, Korona-Bailey J, Mukhopadhyay S. Notes from the Field: Nitazene-Related Deaths — Tennessee, 2019–2021. MMWR, Centers for Disease Control and Prevention, September 16, 2022. cdc.gov
- Tennessee Department of Health. Nitazene-Involved Deaths in Tennessee (overdose surveillance infographic). tn.gov
- Centers for Disease Control and Prevention. About Overdose Prevention (national synthetic opioid data). cdc.gov
- U.S. Drug Enforcement Administration, Diversion Control Division. Nitazenes (scheduling actions and technical information). deadiversion.usdoj.gov
- Vanderbilt University Medical Center. Forgotten opioid has resurfaced as lethal street drug (Pain Medicine review, VUMC and UPMC), September 16, 2025. news.vumc.org
- Notes from the Field: Increased Incidence of Fentanyl-Related Deaths Involving Para-fluorofentanyl or Metonitazene — Knox County, Tennessee. MMWR / NCBI. ncbi.nlm.nih.gov
- Substance Abuse and Mental Health Services Administration (SAMHSA). FindTreatment.gov and National Helpline, 1-800-662-HELP (4357). findtreatment.gov